NO851298L - Fremgangsmaate for fremstilling av nye piperazinderivater - Google Patents

Fremgangsmaate for fremstilling av nye piperazinderivater

Info

Publication number
NO851298L
NO851298L NO851298A NO851298A NO851298L NO 851298 L NO851298 L NO 851298L NO 851298 A NO851298 A NO 851298A NO 851298 A NO851298 A NO 851298A NO 851298 L NO851298 L NO 851298L
Authority
NO
Norway
Prior art keywords
derivative
benzyl
condensing
addition salt
acid addition
Prior art date
Application number
NO851298A
Other languages
English (en)
Other versions
NO163185C (no
Inventor
Hiroshi Ohtaka
Toshiro Kanazawa
Keizo Ito
Goro Tsukamoto
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Publication of NO851298L publication Critical patent/NO851298L/no
Publication of NO163185C publication Critical patent/NO163185C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO851298A 1984-03-30 1985-03-29 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive piperazinderivater. NO163185C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59064464A JPS60222472A (ja) 1984-03-30 1984-03-30 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物

Publications (2)

Publication Number Publication Date
NO851298L true NO851298L (no) 1985-10-01
NO163185C NO163185C (no) 1990-04-18

Family

ID=13258978

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851298A NO163185C (no) 1984-03-30 1985-03-29 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive piperazinderivater.

Country Status (10)

Country Link
US (1) US4663325A (no)
EP (1) EP0159566B1 (no)
JP (1) JPS60222472A (no)
AT (1) ATE31411T1 (no)
CA (1) CA1248110A (no)
DE (1) DE3561199D1 (no)
ES (3) ES8702393A1 (no)
FI (1) FI79101C (no)
GR (1) GR850787B (no)
NO (1) NO163185C (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61161272A (ja) * 1985-01-11 1986-07-21 Kanebo Ltd 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物
US4792553A (en) * 1986-02-04 1988-12-20 Terumo Kabushiki Kaisha Diene derivatives and vasodilators containing the same
FR2614021B1 (fr) * 1987-04-14 1991-03-01 Andre Buzas Derives de la 1-((1,1-diphenyl)-1-alcenyl)-piperazine, procede d'obtention et compositions pharmaceutiques les contenant
DE4108527A1 (de) * 1991-03-15 1992-09-17 Basf Ag Neue 1-(4-cyano-4-aryl-cyclohexyl)piperazine, ihre herstellung und verwendung
AU646926B2 (en) * 1991-03-20 1994-03-10 Duphar International Research B.V. Alkylenedioxyphenyl ether derivatives having anti-ischaemic, memory enhancing and anti-convulsive activity
ES2156934T3 (es) * 1993-12-08 2001-08-01 Alcon Lab Inc Compuestos que presentan una potente actividad de antagonistas del calcio y de antioxidantes y su utilizacion como agentes citoprotectores.
US6387910B1 (en) 1998-01-29 2002-05-14 Akzo Nobel N.V. Drug of improving optic nerve head circulation disorder
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US7433519B2 (en) 2003-04-04 2008-10-07 Avid Technology, Inc. Bitstream format for compressed image data
US7403561B2 (en) 2003-04-04 2008-07-22 Avid Technology, Inc. Fixed bit rate, intraframe compression and decompression of video
US20060135506A1 (en) * 2003-04-22 2006-06-22 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
WO2004093816A2 (en) * 2003-04-22 2004-11-04 Pharmacia Corporation Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent
JP4901474B2 (ja) * 2003-05-30 2012-03-21 ランバクシー ラボラトリーズ リミテッド 置換ピロール誘導体
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
JP2008533044A (ja) * 2005-03-11 2008-08-21 ホン コン ナイトリック オキサイド リミテッド 内皮機能不全、アンギナおよび糖尿病のための組合せ治療
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
ATE551059T1 (de) * 2005-10-26 2012-04-15 Asahi Kasei Pharma Corp Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
KR101329112B1 (ko) * 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US20070238716A1 (en) * 2006-03-14 2007-10-11 Murthy Ayanampudi S R Statin stabilizing dosage formulations
EP2049102A4 (en) * 2006-07-14 2010-12-22 Ranbaxy Lab Ltd POLYMORPHIC FORMS OF AN HMG COA REDUCTASE HEATHER AND USE
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
EP2130828A4 (en) 2007-02-28 2010-12-29 Asahi Kasei Pharma Corp sulfonamide
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
CN102936233B (zh) * 2012-11-16 2016-01-20 葛长乐 一种1-(二(4-氟苯基)甲基)-4-(2,3,4-三甲氧苯基)哌嗪二盐酸盐晶型
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN107636792B (zh) * 2015-10-20 2019-05-14 韩国标准科学研究院 易于位置调节的电子显微镜用电子枪及包括其的电子显微镜
CN109666008A (zh) * 2018-12-31 2019-04-23 辰欣药业股份有限公司 一种盐酸洛美利嗪的合成方法
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB705979A (en) * 1951-03-22 1954-03-24 Henri Morren 1.4-aralkyl piperazines and process for the preparation thereof
FR1312427A (fr) * 1961-04-12 1962-12-21 Science Union Et Compagnie Soc Nouveaux dérivés de la pipérazine et leurs préparations
FR1303080A (fr) * 1961-07-25 1962-09-07 Science Union Et Compagnie Soc Pipérazines disubstituées
NL7306771A (no) * 1972-06-02 1973-12-04
DE2900810A1 (de) * 1979-01-11 1980-07-24 Cassella Ag Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung
GB8320701D0 (en) * 1983-08-01 1983-09-01 Wellcome Found Chemotherapeutic agent

Also Published As

Publication number Publication date
ES556981A0 (es) 1988-01-01
ES8702393A1 (es) 1987-01-01
ES556980A0 (es) 1988-01-01
DE3561199D1 (en) 1988-01-28
CA1248110A (en) 1989-01-03
ES8801237A1 (es) 1988-01-01
FI79101C (fi) 1989-11-10
FI851217L (fi) 1985-10-01
EP0159566A1 (en) 1985-10-30
ES8801236A1 (es) 1988-01-01
FI851217A0 (fi) 1985-03-26
JPH0313232B2 (no) 1991-02-22
EP0159566B1 (en) 1987-12-16
NO163185C (no) 1990-04-18
US4663325A (en) 1987-05-05
FI79101B (fi) 1989-07-31
GR850787B (no) 1985-11-25
ATE31411T1 (de) 1988-01-15
JPS60222472A (ja) 1985-11-07
ES541728A0 (es) 1987-01-01

Similar Documents

Publication Publication Date Title
NO851298L (no) Fremgangsmaate for fremstilling av nye piperazinderivater
NO792119L (no) Analogifremgangsmaate for fremstilling av 2-(2-alkoksyetyl)-2`hydroksyl-6,7-benzomorfaner og syreaddisjonssalter derav
ATE17249T1 (de) 9-(2-(3-indolyl)aethyl)-1-oxa-4,9diazaspiro(5.5)undecan-3-one.
SU645569A3 (ru) Способ получени производных 4-ариламино-6-метилпиримидина
DK326481A (da) Fremgangsmaade til fremstilling af i 5-stillingen substituerede 5,10-dihydro-11h-dibenzo (b,e) (1,4) diazepin-11-oner eller syreadditionssalte deraf
ATE31527T1 (de) P-oxibenzoesaeurederivate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von arzneimitteln mit hypolipaemischer wirkung.
ES8706598A1 (es) Un procedimiento para preparar nuevos derivados de aminocetona
DK154891C (da) Analogifremgangsmaade til fremstilling af thieno-thiazolderivater og deres fysiologisk acceptable syreadditionssalte.
SE7902302L (sv) Nya n-fenylalaninderivat, deras framstellning och deras anvendning som lekemedel
DK16188A (da) Guanidinoeddikesyre- og ethanamidinoeddikesyre-derivater, deres fremstilling og deres anvendelse som soedemidler
KR860004012A (ko) 벤즈아미드의 제조방법
KR860700352A (ko) 2--(1-피페라지닐)-4-치환 페닐퀴놀린 유도체와 그 염의 제조방법
NO855383L (no) Fremgangsmaate for fremstilling av piperazin-derivater.
SE7711146L (sv) Tiaprostaglandiner
ES405651A1 (es) Procedimiento para la preparacion de nuevos acidos 4 - (4 -bifenilil) - 4 - hidroxi - butiricos, sus esteres o lacto- nas.
DK193181A (da) Fremgangmaade til fremstilling af imidazolderivater
SE7611953L (sv) Forfarande for framstellning av aroyl-fenyl-naftalenderivat anvendbara sasom antifertilitets- och antitumormedel
GB1096844A (en) Improvements in or relating to substituted indazole derivative
SE8703494D0 (sv) Mellanprodukter anvendbara vid framstellning av 2-tiofen-ettiksyraderivat
ES519530A0 (es) Procedimiento para la preparacion de tienobenzodiazepinonas sustituidas.
ES526332A0 (es) Procedimiento para preparar nuevos 4-hidroxi-2h-1,2-benzotiazin-3-carboxamida-1,1-dioxidos
ES497949A0 (es) Procedimiento para la preparacion de nuevos 4-amino-2,6-dia-riltetrahidrotiopiranos sustituidos
ES8106143A1 (es) Procedimiento para la preparacion de derivados de cinamoil- piperidinobutirofenona
CH611283A5 (en) Process for the preparation of arylaminopyrimidine derivatives
ATE5775T1 (de) 2-nitronaphtofuranderivate, ihre herstellung und ihre verwendung, insbesondere als zellenwachstumsregulatoren.

Legal Events

Date Code Title Description
MK1K Patent expired